PAS
CAPR icon

Point72 Asia (Singapore)’s Capricor Therapeutics CAPR Stock Holding History

Point72 Asia (Singapore)’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$59.2K Buy
+8,215
New +$60.5K 0.01% 543
2024
Q2 		– Sell
-23,678
Closed -$161K – 1091
2024
Q1 		$161K Buy
+23,678
New +$114K 0.04% 506

Other funds holding CAPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Point72 Asia (Singapore)'s CAPR Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Capricor Therapeutics (CAPR) in Q3 2025: 8,215 shares worth $59.2K. The stake represents 0.01% of the portfolio and ranks #543 among its holdings. This is a return to the name: Point72 Asia (Singapore) previously reported a position in CAPR as recently as Q1 2024.

Point72 Asia (Singapore) first reported a position in CAPR in Q1 2024 and has held it in 2 quarters since. The position peaked at $161K in Q1 2024. 115 funds tracked by Wall St. Rank hold CAPR as of Q3 2025.

  • Point72 Asia (Singapore) held 8,215 shares of Capricor Therapeutics worth $59.2K as of Q3 2025.
  • Capricor Therapeutics was a new Point72 Asia (Singapore) position in Q3 2025.
  • Capricor Therapeutics made up 0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #543 holding.
  • Point72 Asia (Singapore) first reported a position in Capricor Therapeutics in Q1 2024 and has held it in 2 quarters since.
  • Point72 Asia (Singapore)'s Capricor Therapeutics position peaked at $161K in Q1 2024.
  • 115 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.